You are here: Home

  • Fall 2019: We are proud of our Speech-Language Pathology team who gave presentations at several conferences this fall.
  • Fall 2019: Click here to see Dr. Dickerson discuss a PPA case in an on-line CME forum.
  • Summer 2019: Congratulations to Dr. Bonnie Wong who led our group's publication reviewing our approach to the diagnosis and management of Posterior Cortical Atrophy.
  • Spring 2019: I am delighted that a multi-national group of colleagues and I published a summary paper on issues in the development of new treatments for FTD and related disorders.
  • Winter 2018-2019: We are excited to launch our first NIH-funded study of caregivers!
  • Fall 2018: Katie Brandt, our FTD Unit's Director of Caregiver Support and Public Relations, was quoted in an excellent NPR story on Dr. Helen Kales' DICE approach to behavioral symptom management in patients with dementia; our pilot study of DICE in FTD is ongoing.
  • Other news  
  • Welcome to the MGH FTD Unit

    Document Actions

    Welcome to the MGH Frontotemporal Disorders (FTD) Unit, a comprehensive clinical-research unit focused on Frontotemporal Degeneration and related disorders, including Primary Progressive Aphasia (PPA), Semantic Dementia, Corticobasal Degeneration Syndrome (CBD), Progressive Supranuclear Palsy (PSP), Posterior Cortical Atrophy (PCA), FTD-ALS, and related disorders. We also work very actively in the FTD Unit with patients and families with young-onset and atypical forms of Alzheimer's disease.

    The MGH FTD Unit aims to develop better knowledge about and diagnosis and treatment of all forms of FTD and related focal dementia syndromes. We provide comprehensive clinical services related to FTD, including diagnostic assessment, second opinions, comprehensive treatment recommendations, education and counseling, and ongoing monitoring. In addition, specialized services are available in partnership with other local providers when relevant, including genetic counseling and testing, neuropsychological assessment, social work services, occupational/speech/physical therapy, neuropsychiatry, sleep, vision, and hearing assessments. We work in close partnership with other clinicians in the area (including Brigham & Women's Hospital, Beth Israel Hospital, Jamaica Plain VA Aphasia Research Center, and others). In addition, we work in close partnership with the Association for FTD and the Alzheimer's Association.

    We are happy to discuss specific situations over the phone or by email to determine if a referral is appropriate. Please read our introductory brochure for more information.

    We also perform a variety of research that we hope will contribute to better understanding of these disorders, earlier and more precise diagnosis, better prognostication and monitoring, and ultimately treatment.

    We also conduct the MGH FTD Family Study focusing on symptomatic and asymptomatic individuals in families in which FTD affects more than one member.

    The PPA Program aims to better understand and treat primary progressive aphasia syndromes using existing technologies (including speech therapy) and by developing new diagnostic and treatment technologies. We also provide education and counseling related to PPA. Information for clinicians and researchers on our Progressive Aphasia Severity Scale is available here.

    The PCA Program aims to better understand and treat posterior cortical atrophy (PCA) using existing and new technologies and by developing new diagnostic and treatment techniques. We also provide education and counseling related to PCA.

    If you would like to discuss the possibility of scheduling an evaluation in our clinic with Dr. Dickerson or Dr. Eldaief or Dr. Perez, call 617-726-1728. If you are a patient who has been seen at the MGH FTD Unit and would like information on obtaining medical records, click above on the "clinic" link and/or call 617-726-1728. For medication related information, contact this same number.

    Our research is generously funded by the National Institute on Aging, National Institute for Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Communication Disorders and Deafness, the Association for FTD, the Krupp Foundation/Tom Rickles Fund, Tau Consortium, and private donors.

    For further information, contact us at by email at or by telephone at 617-726-5571 (ask for Raseeka O'Chander, Program Manager). Contact for more information about the monthly Boston-area FTD caregiver support group meeting.

    Click here to read our newsletters.

    Contact us
    Click here to email us with any questions or requests regarding new or existing patients and we will do our best to respond within the week.

    Like us! fb
    Future Events
    Our team will be presenting new research at the CNS and ANPA meetings in March